The Raymond and Beverly Sackler Prize in Convergence Research recognizes significant advances in Convergence research.

Far too many diseases do not have a proven means of prevention or effective treatments. We must gain better insights into the biological, environmental, and behavioral influences on these diseases to make a difference for the millions of Americans who suffer from them.

The V Foundation for Cancer Research, Stand Up To Cancer (SU2C), a program of the Entertainment Industry Foundation, and the National Science Foundation collaborated to fund grants for research scholars working within Convergence to spur innovation in new ways of combating cancer.

The Biological Technology Office (BTO) is DARPA’s technology arm focused on leveraging advances in engineering and information sciences to drive and reshape biotechnology for technological advantage. BTO is responsible for all neurotechnology, human-machine interface, human performance, infectious disease, and synthetic biology programs within the agency.

The BRAIN Initiative supports the development and application of innovative technologies—across neuroscience, engineering, computation, and physics—that can create a dynamic understanding of brain function.